RECRUITING

Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to collect normative population data on the ultrasound radiographic parameters used to evaluate hip dysplasia in infants between 32 and 46 weeks of gestational age. This data would be utilized to develop a growth chart with standard deviations for this cohort that would be beneficial in the appropriate treatment of suspected hip dysplasia.

Official Title

Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound

Quick Facts

Study Start:2017-10-25
Study Completion:2024-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03109444

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 6 Weeks
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * newborns born at CRMC (term newborns and pre-mature newborns over 32 weeks gestational age.
  2. * newborns in NICU
  3. * newborns on postpartum floor
  4. * single birth
  5. * multiple births
  6. * normal presentation
  7. * breach presentation
  1. * known neuromuscular or genetic condition predisposing infant to hip dysplasia (i.e. Spina Bifida, Cerebral Palsy),
  2. * inability to follow up (i.e. doesn't live in surrounding area),
  3. * frankly dislocated hips that require immediate treatment,
  4. * any medical condition precluding safe hip ultrasound.

Contacts and Locations

Study Contact

Justin Lee, MPH
CONTACT
559-459-4372
Jlee@fresno.ucsf.edu

Principal Investigator

John Wiemann, MD
PRINCIPAL_INVESTIGATOR
UCSF - Fresno

Study Locations (Sites)

Community Regional Medical Center
Fresno, California, 93721
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • John Wiemann, MD, PRINCIPAL_INVESTIGATOR, UCSF - Fresno

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-10-25
Study Completion Date2024-10-01

Study Record Updates

Study Start Date2017-10-25
Study Completion Date2024-10-01

Terms related to this study

Keywords Provided by Researchers

  • Hip Growth Chart

Additional Relevant MeSH Terms

  • Newborn
  • Hip Dysplasia